Cardiac Dysfunction-ameliorating Agent Or Cardiac Function-maintaining Agent

  • Published: Dec 24, 2008
  • Earliest Priority: Mar 13 2006
  • Family: 6
  • Cited Works: 1
  • Cited by: 0
  • Cites: 0
  • Additional Info:

The full document isn't yet available to us from the patent office.


An object of the present invention is to provide a highly safe oral composition superior in a cardiac dysfunction-ameliorating or cardiac function-maintaining action. The present inventors have conducted intensive studies in an attempt to solve the aforementioned problems and found that use of, particularly, reduced coenzyme Q10 from among highly safe coenzyme Q affords a composition useful for amelioration of cardiac dysfunction and maintenance of cardiac function. Accordingly, the present invention provides a cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent containing reduced coenzyme Q as an active ingredient, and a pharmaceutical product, a food, an animal drug, a feed and the like, which contain the agent.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Dec 24, 2008
  • Application: Mar 9, 2007
    EP EP 07738128 A
  • Priority: Mar 9, 2007
    JP 2007054643 W
  • Priority: Nov 21, 2006
    JP 2006314034 A
  • Priority: Mar 13, 2006
    JP 2006066992 A

Download Citation

Sign in to the Lens